Corcept Therapeutics Inc (CORT)

27.69 +0.23 (+0.84%) USD  |  NASDAQ  |  Aug 19, 16:00
27.69 0.00 (0.00%) After-Hours: 18:39
More

Corcept Therapeutics News

News

Headline
Wire
Time (ET)
Bragar Eagel & Squire, P.C. Is Investigating Medallion, RBB, Agrify, and Corcept and Encourages Investors to Contact the Firm
Globe Newswire
08/15 21:00
Bragar Eagel & Squire, P.C. Is Investigating Medallion, RBB, Agrify, and Corcept and Encourages Investors to Contact the Firm
Globe Newswire
08/10 21:00
JAZZ or CORT: Which Is the Better Value Stock Right Now?
Yahoo
08/09 11:40
Bragar Eagel & Squire, P.C. Is Investigating Corcept, Hannon Armstrong, NIO, and Generac and Encourages Investors to Contact the Firm
Globe Newswire
08/05 21:00
Corcept Therapeutics Q2 EPS, Revenue Higher; Reiterates 2022 Guidance
MT Newswires
08/05 11:34
Corcept (CORT) Down on Q2 Earnings Miss, Revenues Rise Y/Y
Yahoo
08/05 08:25
--HC Wainwright Adjusts Price Target on Corcept Therapeutics to $33 From $29, Reiterates Buy Rating
MT Newswires
08/04 06:59
Corcept Therapeutics (CORT) Q2 2022 Earnings Call Transcript
Yahoo
08/04 00:30
Corcept Therapeutics (CORT) Q2 Earnings Lag Estimates
Yahoo
08/03 17:35
-- Earnings Flash (CORT) CORCEPT THERAPEUTICS INCORPORATED Posts Q2 EPS $0.24
MT Newswires
08/03 16:12
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
Globe Newswire
08/03 16:05
--Truist Securities Downgrades Corcept Therapeutics to Hold From Buy; Price Target is $30
MT Newswires
08/01 08:51
Bragar Eagel & Squire, P.C. Is Investigating Carvana, Corcept, Cassava, and Hannon Armstrong and Encourages Investors to Contact the Firm
Globe Newswire
07/31 21:00
Has Corcept Therapeutics (CORT) Outpaced Other Medical Stocks This Year?
Yahoo
07/29 09:40
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
Globe Newswire
07/27 16:05
Corcept initiated as a buy at Jefferies on 'underappreciated' Cushing's business
SA Breaking News
07/27 11:30
Bragar Eagel & Squire, P.C. Is Investigating Enochian, Corcept, Cassava, and Hannon Armstrong and Encourages Investors to Contact the Firm
Globe Newswire
07/25 21:00
Corcept Therapeutics Incorporated's (NASDAQ:CORT) Stock Is Going Strong: Is the Market Following Fundamentals?
Yahoo
07/22 07:00
Bragar Eagel & Squire, P.C. Is Investigating Enochian, Corcept, Rollins, and the WWE and Encourages Investors to Contact the Firm
Globe Newswire
07/20 21:00
Bragar Eagel & Squire, P.C. Is Investigating Enochian, Corcept, Rollins, and Target and Encourages Investors to Contact the Firm
Globe Newswire
07/15 21:00
3 Biotech Stocks Outperforming a Bear Market
Yahoo
07/15 07:50
Bragar Eagel & Squire, P.C. Is Investigating Corcept, Rollins, Target, and TG Therapeutics and Encourages Investors to Contact the Firm
Globe Newswire
07/10 21:00
Insider Sell: Corcept Therapeutics
MT Newswires
07/08 17:26
Corcept (CORT) Thrives on Korlym Amid Overdependence Concerns
Yahoo
07/05 11:14
Bragar Eagel & Squire, P.C. Is Investigating Enochian, Corcept, Rollins, and Target and Encourages Investors to Contact the Firm
Globe Newswire
07/04 21:00
Bragar Eagel & Squire, P.C. Is Investigating Agrify, Carvana, Enochian, and Corcept and Encourages Investors to Contact the Firm
Globe Newswire
06/29 21:00
Corcept Therapeutics begins phase 3 trial of relacorilant for ovarian cancer
SA Breaking News
06/29 17:21
Corcept Therapeutics Starts Late-Stage Trial in Ovarian Cancer
MT Newswires
06/29 16:55
Corcept Therapeutics Initiates Rosella – A Pivotal Phase 3 Trial in Recurrent, Platinum-Resistant Ovarian Cancer
Globe Newswire
06/29 16:05
Why Corcept's Pill — And Stock — Is Getting Renewed Attention After Abortion Ruling
Yahoo
06/28 16:20
Dow Jones Dips; Donald Trump SPAC Dives On This Move; Apple Stock Whipsaws Amid Wall Street Call
Yahoo
06/27 16:34
After A 20% Rally This Month, Here's Why This Biotech Is Worth Considering
Yahoo
06/27 15:48
Bragar Eagel & Squire, P.C. Is Investigating Unity, Carvana, Enochian, and Corcept and Encourages Investors to Contact the Firm
Globe Newswire
06/24 21:00
Why a Peninsula rare disease drug company is turning toward cancer
Yahoo
06/24 16:11
Corcept Stock Near Buy Point; Strength Rating Jumps To 91
Yahoo
06/23 16:06
ProPhase Labs, Inc. (PRPH) Surges 7.6%: Is This an Indication of Further Gains?
Yahoo
06/22 10:06
Bragar Eagel & Squire, P.C. Is Investigating Carvana, Enochian, Corcept, and Clariant and Encourages Investors to Contact the Firm
Globe Newswire
06/19 21:00
Bragar Eagel & Squire, P.C. Is Investigating Carvana, Enochian, Novartis, and Corcept and Encourages Investors to Contact the Firm
Globe Newswire
06/13 21:00
Is Corcept Therapeutics Incorporated (NASDAQ:CORT) Popular Amongst Insiders?
Yahoo
06/10 08:00
Bragar Eagel & Squire, P.C. Is Investigating Carvana, Enochian, Novartis, and Corcept and Encourages Investors to Contact the Firm
Globe Newswire
06/08 21:00
Corcept Therapeutics to Launch Late-Stage Ovarian Cancer Trial
MT Newswires
06/06 09:31
Corcept Therapeutics to Start Phase 3 Trial of Relacorilant Plus Nab-Paclitaxel in Patients With Platinum-Resistant Ovarian Cancer
Globe Newswire
06/06 08:00
Bragar Eagel & Squire, P.C. Is Investigating Verrica, Gap, and Corcept and Encourages Investors to Contact the Firm
Globe Newswire
06/03 21:00
Bragar Eagel & Squire, P.C. Is Investigating Medallion, Corcept, RBB, and Cassava and Encourages Investors to Contact the Firm
Globe Newswire
05/29 21:00
Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Corcept, and RBB and Encourages Investors to Contact the Firm
Globe Newswire
05/22 21:00
Insider Sell: Corcept Therapeutics
MT Newswires
05/19 17:09
Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Corcept, and RBB and Encourages Investors to Contact the Firm
Globe Newswire
05/16 21:00
Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Corcept, and RBB and Encourages Investors to Contact the Firm
Globe Newswire
05/11 21:00
Bragar Eagel & Squire, P.C. Is Investigating Corcept, RBB, and Verra and Encourages Investors to Contact the Firm
Globe Newswire
05/06 21:00
Corcept Therapeutics Announces First Quarter Financial Results And Provides Corporate Update
Globe Newswire
05/05 16:05
Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Cortexyme, and Corcept and Encourages Investors to Contact the Firm
Globe Newswire
05/01 21:00
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
Globe Newswire
04/28 16:05
Bragar Eagel & Squire, P.C. Is Investigating Cortexyme, Corcept, RBB, and Verra and Encourages Investors to Contact the Firm
Globe Newswire
04/25 21:00
Bragar Eagel & Squire, P.C. Is Investigating Cortexyme, SelectQuote, Corcept, and Core Scientific and Encourages Investors to Contact the Firm
Globe Newswire
04/20 21:00
Bragar Eagel & Squire, P.C. Is Investigating Corcept, Core Scientific, Anavex, and Roblox and Encourages Investors to Contact the Firm
Globe Newswire
04/15 21:00
Bragar Eagel & Squire, P.C. Is Investigating Medallion, Cortexyme, SelectQuote, and Corcept and Encourages Investors to Contact the Firm
Globe Newswire
04/10 21:00
Corcept Therapeutics Announces Appointment of Three Senior Leaders
Globe Newswire
04/07 16:05
Bragar Eagel & Squire, P.C. Is Investigating Corcept and Core Scientific and Encourages Investors to Contact the Firm
Globe Newswire
04/04 21:00
Corcept Therapeutics Completes Phase 2 Miricorilant Trial Enrollment
MT Newswires
04/04 16:30
Corcept completes enrollment in trial to treat patients with antipsychotic-induced weight gain
SA Breaking News
04/04 16:28
Corcept Therapeutics Completes Enrollment in Phase 2 GRATITUDE Study of Miricorilant in Patients with Antipsychotic-Induced Weight Gain
Globe Newswire
04/04 16:05
Moore Kuehn, PLLC Encourages Investors of CORT and CACC to Contact Law Firm
Globe Newswire
03/30 21:20
Bragar Eagel & Squire, P.C. Is Investigating Corcept, Verra, Core Scientific, and Lilium and Encourages Investors to Contact the Firm
Globe Newswire
03/30 21:00
Relacorilant Plus Nab-Paclitaxel Extends Survival in Women with Recurrent, Platinum-resistant Ovarian Cancer
Globe Newswire
03/30 16:05
Bragar Eagel & Squire, P.C. Is Investigating Corcept, Verra, Core Scientific, and Applied Therapeutics and Encourages Investors to Contact the Firm
Globe Newswire
03/25 21:00
Bragar Eagel & Squire, P.C. Is Investigating Porch, Virgin Galactic, Corcept, and Verra and Encourages Investors to Contact the Firm
Globe Newswire
03/20 21:00
Bragar Eagel & Squire, P.C. Is Investigating Verra, Corcept, Core Scientific, and Applied Therapeutics and Encourages Investors to Contact the Firm
Globe Newswire
03/14 21:34
Bragar Eagel & Squire, P.C. Is Investigating Corcept, Medallion, Clariant, and Anavex and Encourages Investors to Contact the Firm
Globe Newswire
03/09 21:00
Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Corcept, and Clariant and Encourages Investors to Contact the Firm
Globe Newswire
03/04 21:00
Corcept Therapeutics to Host Ovarian Cancer Program Update on Thursday, March 31, 2022
Globe Newswire
03/01 16:05
Bragar Eagel & Squire, P.C. Is Investigating Agrify, CareDx, Inc., Medallion Financial, and Corcept and Encourages Investors to Contact the Firm
Globe Newswire
02/27 21:00
Bragar Eagel & Squire, P.C. Is Investigating Agrify, CareDx, Medallion, and Corcept and Encourages Investors to Contact the Firm
Globe Newswire
02/21 21:00
Bragar Eagel & Squire, P.C. Is Investigating Agrify, CareDx, Medallion, and Corcept and Encourages Investors to Contact the Firm
Globe Newswire
02/16 21:00
Corcept climbs after Q4 earnings amid positive views from analysts
SA Breaking News
02/16 14:50
Corcept Therapeutics Reports Higher Q4 Earnings, Revenue
MT Newswires
02/15 16:37
-- Earnings Flash (CORT) CORCEPT THERAPEUTICS INCORPORATED Reports Q4 EPS $0.35, vs. Street Est of $0.35
MT Newswires
02/15 16:06
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2021 Audited Financial Results and Provides Corporate Update
Globe Newswire
02/15 16:05
Earnings Reaction History: Corcept Therapeutics, 57.1% Follow-Through Indicator, 5.0% Sensitive
MT Newswires
02/15 12:23
Bragar Eagel & Squire, P.C. Is Investigating Agrify, CareDx, Medallion, and Corcept and Encourages Investors to Contact the Firm
Globe Newswire
02/11 21:00
Corcept Therapeutics to Announce Fourth Quarter and Full-year 2021 Financial Results, Provide Corporate Update and Host Conference Call
Globe Newswire
02/08 16:05
SHAREHOLDER ALERT: Morris Kandinov Investigating QS, RMO, XELA, and CORT; Shareholders are Encouraged to Contact the Firm
Globe Newswire
02/07 18:14
Bragar Eagel & Squire, P.C. Is Investigating Corcept, Agrify, Affirm Holdings, and Medallion Financial and Encourages Investors to Contact the Firm
Globe Newswire
02/06 21:00
Canaccord Genuity Starts Corcept Therapeutics at Buy with $30 Price Target
MT Newswires
02/02 11:06
Bragar Eagel & Squire, P.C. Is Investigating Agrify, CareDX, Medallion, and Corcept and Encourages Investors to Contact the Firm
Globe Newswire
01/31 21:00
--Truist Securities Starts Corcept Therapeutics at Buy With $30 Price Target
MT Newswires
01/28 09:44
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT
PR Newswire
01/27 22:10
Moore Kuehn, PLLC Encourages Investors of CORT and CACC to Contact Law Firm
PR Newswire
01/27 13:36
Bragar Eagel & Squire, P.C. Is Investigating Corcept, Cronos, Everbridge, and Hollysys and Encourages Investors to Contact the Firm
Globe Newswire
01/26 21:00
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT
Globe Newswire
01/23 13:20
Bragar Eagel & Squire, P.C. Is Investigating Natera, Nuvei, Corcept Therapeutics, and Agrify and Encourages Investors to Contact the Firm
Globe Newswire
01/21 21:00
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT
PR Newswire
01/17 19:49
Bragar Eagel & Squire, P.C. Is Investigating Tecnoglass, Everbridge, Corcept, and Agrify and Encourages Investors to Contact the Firm
Globe Newswire
01/16 21:00
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT
Globe Newswire
01/13 08:46
Bragar Eagel & Squire, P.C. Is Investigating Corcept, Agrify, Affirm Holdings, and Medallion Financial and Encourages Investors to Contact the Firm
Globe Newswire
01/11 21:00
Bragar Eagel & Squire, P.C. Is Investigating Corcept, Agrify, Affirm Holdings, and Medallion Financial and Encourages Investors to Contact the Firm
Globe Newswire
01/06 21:00
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT
PR Newswire
01/06 18:20
CORCEPT ALERT: Bragar Eagel & Squire, P.C. is Investigating Corcept Therapeutics Inc. on Behalf of Corcept Stockholders and Encourages Investors to Contact the Firm
Globe Newswire
12/27 21:00
CORCEPT ALERT: Bragar Eagel & Squire, P.C. is Investigating Corcept Therapeutics Inc. on Behalf of Corcept Stockholders and Encourages Investors to Contact the Firm
Globe Newswire
12/22 21:00
SHAREHOLDER ALERT: Morris Kandinov Investigating CORT, MTCH, LDI, and ODT; Shareholders are Encouraged to Contact the Firm
Globe Newswire
12/22 16:53
Corcept Therapeutics Announces Final Results of Previously Announced Tender Offer
Globe Newswire
12/20 16:05
Corcept Therapeutics Announces Preliminary Results of Previously Announced Tender Offer
Globe Newswire
12/16 08:00
CORCEPT ALERT: Bragar Eagel & Squire, P.C. is Investigating Corcept Therapeutics Inc. on Behalf of Corcept Stockholders and Encourages Investors to Contact the Firm
Globe Newswire
12/15 21:00
Corcept Therapeutics Announces Waiver of Condition to its Tender Offer for Common Shares
Globe Newswire
12/15 08:00
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT
PR Newswire
12/13 23:25
Corcept Therapeutics Inc. Investors: Company Investigated by the Portnoy Law Firm
Globe Newswire
12/09 16:43
Top Midday Decliners
MT Newswires
12/08 14:21
Corcept Therapeutics Shares Fall Sharply in Afternoon Trading Following Tender Offer Extension
MT Newswires
12/08 12:59
DWAC, EFOI and AVCT among mid-day movers
SA Breaking News
12/08 12:34
Inotiv, Theravance Biopharma leads healthcare gainers; Radius Health, Ensysce Biosciences among major losers
SA Breaking News
12/08 11:13
Corcept Therapeutics Announces Extension of Previously Announced Tender Offer
Globe Newswire
12/08 08:00
Corcept Therapeutics (CORT) Alert: Shareholder Class Action In Part Survives Motion to Dismiss; Should Management be Held Accountable for Investors' Losses? Contact Johnson Fistel
Globe Newswire
11/24 09:04
Sector Update: Health Care Stocks Adding Support Shortly Before Monday Close
MT Newswires
11/08 15:59
Sector Update: Health Care Stocks Edging Higher in Monday Trading
MT Newswires
11/08 13:01
Corcept Therapeutics Launches Tender Offer For Up to 10 Million Shares; Stock Soars
MT Newswires
11/08 10:56
Corcept Therapeutics Announces Commencement of Tender Offer to Purchase up to 10 Million Shares of its Common Stock
Globe Newswire
11/08 08:30
-- Earnings Flash (CORT) CORCEPT THERAPEUTICS INCORPORATED Posts Q3 EPS $0.30, vs. Street Est of $0.25
MT Newswires
11/03 16:17
Corcept Therapeutics Announces Third Quarter Financial Results And Provides Corporate Update
Globe Newswire
11/03 16:05
Positive Results Presented at ESMO 2021 From Randomized, Controlled, Phase 2 Trial of Relacorilant in Patients with Recurrent Platinum-Resistant Ovarian Cancer
Globe Newswire
09/17 08:30
Insider Sell: Corcept Therapeutics
MT Newswires
09/16 08:02
Corcept Announces Presentation of Positive Results From Randomized, Controlled, Phase 2 Trial of Relacorilant in Patients With Recurrent Platinum-Resistant Ovarian Cancer at ESMO 2021
Globe Newswire
09/09 16:05
Insider Sell: Corcept Therapeutics
MT Newswires
09/03 17:16
William Guyer to join Corcept as Chief Development Officer
Globe Newswire
08/12 17:00
-- Earnings Flash (CORT) CORCEPT THERAPEUTICS INCORPORATED Reports Q2 EPS $0.30, vs. Street Est of $0.17
MT Newswires
07/29 16:08
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
Globe Newswire
07/29 16:05
Corcept Therapeutics To Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
Globe Newswire
07/22 16:05
Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer
Globe Newswire
07/12 08:30
--HC Wainwright Adjusts Corcept Therapeutics' Price Target to $29 From $32, Keeps Buy Rating
MT Newswires
06/23 07:35
Sector Update: Health Care Stocks Manage Narrow Rise as Biotechs Flatten
MT Newswires
06/22 15:59
Sector Update: Health Care Stocks Erasing Mid-Morning Weakness
MT Newswires
06/22 13:22
Corcept Therapeutics Stops Late-Stage Study of Combination Therapy Against Pancreatic Cancer; Shares Down Midday
MT Newswires
06/22 11:49
Corcept shares slide after stopping enrollment in late-stage pancreatic cancer trial
SA Breaking News
06/22 08:57
Preliminary Results From RELIANT Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
Globe Newswire
06/22 08:30
SHAREHOLDER ALERT: Barr Law Group Investigating CORT, SEMMX, MSEIX, and MIMFX; Shareholders are Encouraged to Contact the Firm
Globe Newswire
06/16 05:00
Corcept Therapeutics Announces Settlement Deal for Patent Dispute With Sun Pharmaceutical Industries
MT Newswires
06/15 09:44
Corcept Therapeutics Settles Patent Litigation with Sun Pharmaceutical
Globe Newswire
06/15 08:30
Corcept Therapeutics Appoints Joshua M. Murray to Board of Directors
Globe Newswire
06/10 07:30
-- Earnings Flash (CORT) CORCEPT THERAPEUTICS INCORPORATED Reports Q1 EPS $0.20, vs. Street Est of $0.19
MT Newswires
05/06 16:46
Corcept Therapeutics Provides Clinical Update and Announces First Quarter 2021 Financial Results
Globe Newswire
05/06 16:10
Corcept Therapeutics Observes Large Reductions of Liver Fat and Transient Liver Enzyme Elevations in Phase 2 Trial of Miricorilant as a Potential Treatment for Patients with Nonalcoholic Steatohepatitis (NASH)
Globe Newswire
05/06 16:05
Addition of Relacorilant to Nab-Paclitaxel Improves Progression Free Survival (PFS) in Controlled, Phase 2 trial of 178 Patients with Platinum Resistant Ovarian Cancer
Globe Newswire
05/06 16:01
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
Globe Newswire
04/29 16:05
Corcept lower after NASH trial shows ‘suspended’ in federal register
SA Breaking News
04/08 15:06
Corcept Therapeutics Initiates Early-Stage Relacorilant-Keytruda Trial to Treat Adrenal Cancer
MT Newswires
03/15 08:10
Corcept starts enrollment in early-stage relacorilant-keytruda adrenal cancer study
SA Breaking News
03/15 07:46
Corcept Therapeutics Initiates Phase 1b Trial of Relacorilant Plus Pembrolizumab (Keytruda®) in Patients with Adrenal Cancer with Cortisol Excess
Globe Newswire
03/15 07:30
Corcept Therapeutics Names CFO
MT Newswires
03/02 05:50
Corcept Therapeutics Expands Executive Team; Atabak Mokari Joins As Chief Financial Officer; Charles Robb Named Chief Business Officer
Globe Newswire
03/01 16:05
Corcept Therapeutics EPS beats by $0.06, misses on revenue
SA Breaking News
02/23 17:00
-- Earnings Flash (CORT) CORCEPT THERAPEUTICS INCORPORATED Posts Q4 EPS $0.27
MT Newswires
02/23 16:07
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2020 Audited Financial Results
Globe Newswire
02/23 16:05
Wall Street Tips Lower Pre-Bell, Consolidating After New Highs on Stimulus Bill Progress
MT Newswires
02/09 09:17
Corcept Therapeutics Sees Lower EPS, Revenue in Q4
MT Newswires
02/09 04:26
Corcept Therapeutics Announces Fourth Quarter, Full-Year 2020 Preliminary Selected Financial Results and 2021 Revenue Guidance; Provides Corporate Update
Globe Newswire
02/08 16:05
Corcept Therapeutics Q4 2020 Earnings Preview
SA Breaking News
02/07 17:35
Notable earnings after Monday's close
SA Breaking News
02/07 17:35
Corcept Therapeutics to Announce Preliminary Selected Financial Results, Provide Corporate Update and Host Conference Call
Globe Newswire
02/01 16:05
--Analyst Actions: HC Wainwright Adjusts Corcept Therapeutics' Price Target to $32 From $22, Keeps at Buy
MT Newswires
11/27 07:02
Corcept Therapeutics Appoints Gillian M. Cannon, PhD, to Board of Directors
Globe Newswire
11/23 17:00
After Hours Watch List Scorecard: CORT, SONO, ZTO
MT Newswires
11/19 17:31
Sector Update: Health Care Stocks Back Near Even At Thursday Close
MT Newswires
11/19 15:58
Modest Decline for Health Care Stocks This Afternoon
MT Newswires
11/19 13:38
Corcept Therapeutics Reaches Record High After Appeals Panel Upholds Patent
MT Newswires
11/19 11:45
Medigus, Aptevo Therapeutics leads healthcare gainers; MeiraGTx Holdings, Kintara Therapeutics among major losers
SA Breaking News
11/19 11:00
Thinking about buying stock in Aptevo Therapeutics, Electrameccanica Vehicles, AstraZeneca, Corcept Therapeutics, or 22nd Century Group?
PR Newswire
11/19 08:30
LB, YY, BERY and NKLA among premarket gainers
SA Breaking News
11/19 08:29
MT Newswires After Hours Watch List: CORT, SONO, ZTO
MT Newswires
11/18 17:53
U.S. Patent Trial and Appeals Board Affirms Validity of All Claims of Corcept’s U.S. Patent No.10,195,214
Globe Newswire
11/18 17:40
Market Chatter: US Patent Trial Board Reportedly Upholds Corcept's Korlym Patent Against Teva Challenge; CORT Jumps 23% After-Hours
MT Newswires
11/18 17:27
Corcept wins patent ruling in Teva's Korlym challenge
SA Breaking News
11/18 17:26
--Analyst Actions: HC Wainwright Adjusts Corcept Therapeutics' Price Target to $22 From $18, Keeps Buy Rating
MT Newswires
11/04 08:13
Corcept Therapeutics -5% after Q3 miss and lower guidance
SA Breaking News
11/03 17:19
Corcept Therapeutics Posts Mixed Q3 vs Street Views, Narrows Guidance, To Repurchase $200 Million Shares
MT Newswires
11/03 16:16
Corcept Therapeutics EPS beats by $0.01, misses on revenue
SA Breaking News
11/03 16:07
-- Earnings Flash (CORT) CORCEPT THERAPEUTICS INCORPORATED Posts Q3 EPS $0.24, vs. Street Est of $0.23
MT Newswires
11/03 16:06
Corcept Therapeutics Announces Third Quarter 2020 Financial Results and Provides Corporate Update
Globe Newswire
11/03 16:05
Notable earnings after Tuesday's close
SA Breaking News
11/02 17:35
Corcept Therapeutics Q3 Earnings Preview
SA Breaking News
11/02 13:05
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
Globe Newswire
10/27 16:05
SHAREHOLDER ALERT: Kaskela Law LLC Announces Stockholder Investigation of Corcept Therapeutics Incorporated (CORT) and Encourages Long-Term CORT Stockholders to Contact the Firm
PR Newswire
09/29 09:00
Corcept Therapeutics Begins Second Phase 2 Study of Miricorilant for Treatment of Olanzapine-Induced Weight Gain
MT Newswires
09/10 10:30
Enrollment underway in Corcept Therapeutics' mid-stage miricorilant study for APIWG
SA Breaking News
09/10 10:13
Corcept Therapeutics Initiates Second Phase 2 Trial of Miricorilant to Treat Weight Gain Caused by Antipsychotic Medication
Globe Newswire
09/10 08:30
Crinetics Pharma to advance ACTH antagonist candidate into the clinic
SA Breaking News
09/04 08:10
AMRN, VXRT, HOME and GOGO among midday movers
SA Breaking News
09/02 12:43
--Analyst Actions: Jefferies Downgrades Corcept Therapeutics to Hold From Buy; Price TargetUnchanged at $16
MT Newswires
08/05 10:03
Sector Update: Health Care Stocks Trading Flat-to-Higher During Premarket Wednesday
MT Newswires
08/05 09:22
NKLA, BYND among premarket losers
SA Breaking News
08/05 08:19
Corcept Therapeutics Posts Higher Q2 Non-GAP Net Income
MT Newswires
08/05 07:46
-- Earnings Flash (CORT) CORCEPT THERAPEUTICS INCORPORATED Reports Q2 EPS $0.32, vs. Street Est of $0.21
MT Newswires
08/04 16:33
Corcept Therapeutics Announces Second Quarter 2020 Financial Results and Provides Corporate Update
Globe Newswire
08/04 16:05
Notable earnings after Tuesday's close
SA Breaking News
08/03 17:35
Corcept Therapeutics Q2 Earnings Preview
SA Breaking News
08/03 17:35
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
Globe Newswire
07/28 16:05
Corcept Therapeutics Enrolls First Patient in Cushing's Syndrome Trial
MT Newswires
07/28 10:20
Corcept launches 2nd late-stage study of relacorilant in cortisol disorder
SA Breaking News
07/28 08:57
Corcept Therapeutics Initiates Phase 3 Trial of Relacorilant in Patients with Cushing’s Syndrome of Adrenal Origin
Globe Newswire
07/28 08:30
Corcept completes enrollment in mid-stage study of relacorilant in ovarian cancer
SA Breaking News
07/23 09:50
Corcept Therapeutics Completes Enrollment in Controlled, Phase 2 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Ovarian Cancer
Globe Newswire
07/23 08:30
Corcept Therapeutics initiates late-study for Relacorilant doublet therapy in pancreatic cancer
SA Breaking News
07/01 12:02
Corcept Starts Late-Stage Trial of Relacorilant in Combination with Nab-Paclitaxel for Metastatic Pancreatic Cancer
MT Newswires
06/30 16:31
Corcept Therapeutics Initiates Phase 3 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
Globe Newswire
06/30 16:05
Corcept Therapeutics to Present Data at the American Association of Cancer Research Annual Meeting
Globe Newswire
06/15 08:30
Corcept Therapeutics to Present Data at the American Society of Clinical Oncology Annual Meeting
Globe Newswire
05/14 16:05
Sector Update: Health Care Stocks Flat-to-Higher During Pre-Bell Tuesday
MT Newswires
05/05 09:23
MT Newswires After-Hours News Movers
MT Newswires
05/04 17:49
Corcept Therapeutics Q1 Results Rise from Year Ago, Reaffirms Revenue Guidance - Stock Up 4% After-Hours
MT Newswires
05/04 17:26
Corcept Therapeutics Announces First Quarter 2020 Financial Results And Provides Corporate Update
Globe Newswire
05/04 16:05
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
Globe Newswire
04/27 16:05
CORCEPT THERAPEUTICS PUBLISHES ABSTRACT IN THE JOURNAL OF THE ENDOCRINE SOCIETY
Globe Newswire
04/01 08:30
Corcept Therapeutics Appoints Gregg Alton to Board of Directors
Globe Newswire
03/12 08:30
--Analyst Actions: Cantor Fitzgerald Lifts Corcept Therapeutics Price Target to $15 From $14, Maintains Neutral Rating
MT Newswires
02/21 12:02
Corcept Q4 Adjusted Profit Tops Street Mark, Revenue Meets View; Shares Rise
MT Newswires
02/21 07:16
Corcept Therapeutics Announces Fourth Quarter And Full-Year 2019 Audited Financial Results And Provides Corporate Update
Globe Newswire
02/20 16:05
Corcept Therapeutics to Announce Audited Financial Results, Provide Corporate Update and Host Conference Call
Globe Newswire
02/13 16:05
Corcept prevails in Korlym patent challenge; shares up 4%
SA Breaking News
02/10 13:38
MT Newswires After-Hours News Movers
MT Newswires
01/30 17:55
Corcept Therapeutics Gains 2% - Q4 Sales Seen Topping Estimates, 2020 Sales Outlook Above Street
MT Newswires
01/30 16:56
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2019 Preliminary Selected Financial Results; Provides 2020 Revenue Guidance
Globe Newswire
01/30 16:05
Shareholder Alert: Robbins LLP Announces Another Complaint Filed Against Corcept Therapeutics Incorporated (CORT)
Business Wire
12/26 19:25
Corcept Therapeutics Announces Third quarter 2019  Financial Results and provides corporate update
Globe Newswire
11/07 16:05
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
Globe Newswire
10/31 16:05
Evercore likes 10x Genomics in premarket analyst action
SA Breaking News
09/24 08:09
Analyst Actions: Jefferies Initiates Coverage on Corcept Therapeutics With Buy Rating, $20 Price Target
MT Newswires
09/24 07:33
Corcept Therapeutics Appoints Kimberly Park to Board of Directors
Globe Newswire
09/18 08:30
Analyst Actions: HC Wainwright Initiates Coverage on Corcept Therapeutics With Buy Rating, $18 Price Target
MT Newswires
09/06 08:36
Cantor likes Durect in premarket analyst action
SA Breaking News
09/06 08:07
Corcept Secures Notice of Allowance for Additional Korlym Patent
MT Newswires
08/29 06:09
Corcept nabs U.S. patent covering Korlym with food
SA Breaking News
08/28 16:14
Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushing’s Syndrome
Globe Newswire
08/28 16:05
Aphria leads healthcare gainers; Acorda Therapeutics and Ekso Bionics Holdings among losers
SA Breaking News
08/02 11:02
Corcept Therapeutics Announces Second Quarter 2019 Financial Results and Provides Corporate Update
Globe Newswire
08/01 16:05
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
Globe Newswire
07/25 16:05
India's Sun Pharma Seeks FDA Nod for Generic Version of Corcept's Abortion Drug Korlym Mifepristone
MT Newswires
06/11 16:55
Sun files for generic version of Corcept's Korlym
SA Breaking News
06/11 16:29
Corcept Therapeutics to Present Data from Phase 1/2 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Solid Tumors at the American Society of Clinical Oncology Annual Meeting
Globe Newswire
05/28 08:05
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Corcept, Mobile TeleSystems, Healthcare Services, and American Renal and Encourages Investors to Contact the Firm
Globe Newswire
05/16 22:00
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, HCSG, BA and NOK
Globe Newswire
05/13 09:30
DEADLINE TODAY: Rosen Law Firm Reminds Corcept Therapeutics Incorporated Investors of Important May 13th Deadline in Securities Class Action Lawsuit - CORT
Globe Newswire
05/13 09:21
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In NIO, CORT, HCSG or FCHS To Contact The Firm
Globe Newswire
05/12 10:20
DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Globe Newswire
05/10 12:00
MTNewswires After-Hours News Movers
MT Newswires
05/09 17:55
Corcept Therapeutics Q1 Mixed vs Estimates, Reaffirms Revenue Guidance - Stock Softer After-Hours
MT Newswires
05/09 17:35
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Corcept Therapeutics Incorporated 
Globe Newswire
05/09 17:21
Corcept Therapeutics Announces First Quarter 2019 Financial Results and Provides Corporate Update
Globe Newswire
05/09 16:05
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
Globe Newswire
05/09 15:29
CLASS ACTION UPDATE for CORT, NIO, MBT and NOK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
05/09 09:44
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Corcept, Mobile TeleSystems, Healthcare Services, and American Renal and Encourages Investors to Contact the Firm
Globe Newswire
05/09 05:00
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Corcept Therapeutics Incorporated
Globe Newswire
05/08 18:54
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Globe Newswire
05/03 20:28
CLASS ACTION UPDATE for CORT, WTW, CTL and ZGNX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
05/03 10:30